drugset / Trial / NCT03716076

Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study

NCT03716076

Phase 4 Completed 50 enrolled University of British Columbia
RandomizedParallel-groupDouble-blindDiagnostic

Summary

Relationship between carbetocin dose on transmural dispersion of repolarization (TDR).

Timeline

Start
2018-11-01
Primary completion
2019-06-15
Completion
2020-04-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbetocin Peptide 50 ug Intravenous
Subject Carbetocin Peptide 100 ug Intravenous